title: Dual-route tranexamic acid to reduce blood loss in coronary artery bypass graft surgery: a randomized controlled trial.
authors.affiliation: Department of Pathology and Laboratory Medicine, University of Saskatchewan, Saskatoon, SK, Canada.|Royal University Hospital, Saskatoon, SK, Canada.
authors.forename: Oksana
authors.initials: O
authors.lastname: Prokopchuk-Gauk
authors.affiliation: Clinical Perfusion, Royal University Hospital, Saskatoon, SK, Canada.
authors.forename: Mark W
authors.initials: MW
authors.lastname: Rosin
authors.affiliation: Division of Cardiac Surgery, Department of Surgery, University of Saskatchewan, Saskatoon, SK, Canada.|Royal University Hospital, Saskatoon, SK, Canada.
authors.forename: Taras R
authors.initials: TR
authors.lastname: Mycyk
authors.affiliation: Department of Community Health and Epidemiology, University of Saskatchewan, Saskatoon, SK, Canada.
authors.forename: Hyun J
authors.initials: HJ
authors.lastname: Lim
authors.affiliation: Division of Hematology, Department of Medicine, University of Saskatchewan, Saskatoon, SK, Canada. kelsey.brose@saskcancer.ca.|Royal University Hospital, Saskatoon, SK, Canada. kelsey.brose@saskcancer.ca.
authors.forename: Kelsey
authors.initials: K
authors.lastname: Brose
mesh_terms: D000368:Aged; D000933:Antifibrinolytic Agents / Q000008:administration & dosage* / Q000627:therapeutic use*; D016063:Blood Loss, Surgical / Q000517:prevention & control*; D001026:Coronary Artery Bypass / Q000009:adverse effects* / Q000379:methods; D003422:Critical Care; D004311:Double-Blind Method; D005260:Female; D006801:Humans; D008136:Longevity; D008297:Male; D008875:Middle Aged; D011446:Prospective Studies; D014148:Tranexamic Acid / Q000008:administration & dosage* / Q000627:therapeutic use*; D016896:Treatment Outcome
chemical_list: D000933:Antifibrinolytic Agents; D014148:Tranexamic Acid